| Application no. and date | 15760604.7 (espacenet) (Federated) (European Patent Register), 20150828 | | Patent/reg. no. and date | DK/EP 3186281, 20190410 | | Publication date | 20170705 | | Priority no. and date | US 201462043351 P, 20140828 | | EP pub. no. and date |
EP 3186281 20170705 | | Effective date | | | Applicant/owner | Halozyme, Inc., 11388 Sorrento Valley Road
San Diego, CA 92121, US | | Applicant ref. no. | 6.1904.001 | | Inventor | THOMPSON, Curtis, B., 29 East F Street
Encinitas, CA 92024, US,
ROSENGREN, Sanna, 150 Rodney Avenue
Encinitas, CA 92024, US,
SHEPARD, H., Michael, 13225 Bavarian Drive
San Diego, CA 92129, US | | Representative | Holme Patent A/S, Valbygårdsvej 33, 1, 2500 Valby, DK | | Opponent | | | IPC Class | A61K 31/573 (2006.01) , A61K 38/47 (2006.01) , A61K 39/395 (2006.01) , C07K 16/28 (2006.01) | | Title | Kombinationsterapi med et hyaluronan-nedbrydende enzym og en immun-checkpoint-inhibitor | | Int. application no. | US2015047588 | | Int. publication no. | WO2016033555 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
